「and」の検索結果
113件：71～75件目を表示
-
发表论文 | 研究与开发 | 千寿制药株式会社
1、内 野 美 樹＊2 ＊1 千寿製薬株式会社 研究開発本部 メディカルアフェアーズ部 ＊2 ケイシン五反田アイクリニック 医学と薬学, 83(1) 1-11, 2026 Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Parti...
http://www.senju.co.jp/chinese/rd/thesis/ -
CEO Message | About Senju | SENJU Pharmaceutical
ablished in 1947, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&D capabilities.T...
https://www.senju.co.jp/english/about/message.html -
Publications | Research & Development | SENJU Pharmaceutica
1、内 野 美 樹＊2 ＊1 千寿製薬株式会社 研究開発本部 メディカルアフェアーズ部 ＊2 ケイシン五反田アイクリニック 医学と薬学, 83(1) 1-11, 2026 Results of a Randomized, Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Parti...
http://www.senju.co.jp/english/rd/thesis/ -
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r...
https://www.senju.co.jp/english/products/mytearv.html -
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r...
http://www.senju.co.jp/english/products/mytearv.html